ICU Medical ROA 2010-2025 | ICUI
Current and historical return on assets (ROA) values for ICU Medical (ICUI) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| ICU Medical ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-03-31 | $-0.09B | $4.19B | -2.19% |
| 2024-12-31 | $-0.12B | $4.20B | -2.74% |
| 2024-09-30 | $-0.11B | $4.31B | -2.55% |
| 2024-06-30 | $-0.07B | $4.29B | -1.62% |
| 2024-03-31 | $-0.06B | $4.29B | -1.35% |
| 2023-12-31 | $-0.03B | $4.38B | -0.68% |
| 2023-09-30 | $-0.03B | $4.38B | -0.65% |
| 2023-06-30 | $-0.05B | $4.46B | -1.09% |
| 2023-03-31 | $-0.05B | $4.47B | -1.02% |
| 2022-12-31 | $-0.07B | $4.52B | -1.62% |
| 2022-09-30 | $-0.04B | $4.45B | -0.97% |
| 2022-06-30 | $0.01B | $4.59B | 0.18% |
| 2022-03-31 | $0.04B | $4.75B | 1.60% |
| 2021-12-31 | $0.10B | $1.88B | 5.65% |
| 2021-09-30 | $0.11B | $1.84B | 6.08% |
| 2021-06-30 | $0.10B | $1.80B | 5.83% |
| 2021-03-31 | $0.09B | $1.77B | 5.28% |
| 2020-12-31 | $0.09B | $1.76B | 4.85% |
| 2020-09-30 | $0.08B | $1.73B | 4.62% |
| 2020-06-30 | $0.08B | $1.86B | 4.80% |
| 2020-03-31 | $0.09B | $1.82B | 5.20% |
| 2019-12-31 | $0.10B | $1.69B | 6.21% |
| 2019-09-30 | $0.07B | $1.64B | 4.58% |
| 2019-06-30 | $0.05B | $1.62B | 2.95% |
| 2019-03-31 | $0.06B | $1.61B | 3.51% |
| 2018-12-31 | $0.03B | $1.59B | 1.89% |
| 2018-09-30 | $0.09B | $1.55B | 5.68% |
| 2018-06-30 | $0.09B | $1.53B | 5.70% |
| 2018-03-31 | $0.02B | $1.49B | 1.20% |
| 2017-12-31 | $0.07B | $1.50B | 4.62% |
| 2017-09-30 | $0.03B | $1.52B | 2.24% |
| 2017-06-30 | $0.05B | $1.49B | 4.41% |
| 2017-03-31 | $0.10B | $1.47B | 11.56% |
| 2016-12-31 | $0.06B | $0.71B | 9.51% |
| 2016-09-30 | $0.06B | $0.69B | 9.02% |
| 2016-06-30 | $0.06B | $0.66B | 8.83% |
| 2016-03-31 | $0.05B | $0.64B | 8.68% |
| 2015-12-31 | $0.05B | $0.63B | 7.62% |
| 2015-09-30 | $0.05B | $0.61B | 8.26% |
| 2015-06-30 | $0.04B | $0.57B | 6.75% |
| 2015-03-31 | $0.03B | $0.55B | 5.41% |
| 2014-12-31 | $0.03B | $0.54B | 4.96% |
| 2014-09-30 | $0.03B | $0.53B | 6.23% |
| 2014-06-30 | $0.04B | $0.52B | 7.42% |
| 2014-03-31 | $0.04B | $0.51B | 7.89% |
| 2013-12-31 | $0.04B | $0.50B | 8.61% |
| 2013-09-30 | $0.04B | $0.47B | 8.72% |
| 2013-06-30 | $0.04B | $0.45B | 9.24% |
| 2013-03-31 | $0.04B | $0.44B | 10.04% |
| 2012-12-31 | $0.04B | $0.43B | 10.18% |
| 2012-09-30 | $0.05B | $0.41B | 12.18% |
| 2012-06-30 | $0.04B | $0.39B | 11.94% |
| 2012-03-31 | $0.04B | $0.38B | 12.33% |
| 2011-12-31 | $0.04B | $0.36B | 12.75% |
| 2011-09-30 | $0.04B | $0.34B | 10.53% |
| 2011-06-30 | $0.04B | $0.35B | 10.89% |
| 2011-03-31 | $0.03B | $0.33B | 11.09% |
| 2010-12-31 | $0.03B | $0.31B | 10.14% |
| 2010-09-30 | $0.03B | $0.30B | 9.13% |
| 2010-06-30 | $0.02B | $0.29B | 8.05% |
| 2010-03-31 | $0.02B | $0.29B | 7.30% |
| 2009-12-31 | $0.03B | $0.31B | 8.25% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.233B | $2.382B |
| ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.329B | 27.82 |
| Boston Scientific (BSX) | United States | $151.540B | 37.94 |
| Stryker (SYK) | United States | $146.015B | 30.53 |
| EssilorLuxottica (ESLOY) | France | $127.709B | 0.00 |
| Medtronic (MDT) | Ireland | $109.786B | 15.56 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.554B | 0.00 |
| Haleon (HLN) | United Kingdom | $49.214B | 28.03 |
| ResMed (RMD) | United States | $36.648B | 27.53 |
| Agilent Technologies (A) | United States | $32.650B | 21.28 |
| GE HealthCare Technologies (GEHC) | United States | $32.569B | 15.46 |
| Terumo (TRUMY) | Japan | $26.857B | 34.88 |
| Insulet (PODD) | United States | $22.464B | 88.18 |
| Koninklijke Philips (PHG) | Netherlands | $21.600B | 15.53 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.095B | 11.62 |
| Baxter (BAX) | United States | $15.380B | 11.48 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.819B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.043B | 21.03 |
| Lantheus Holdings (LNTH) | United States | $5.509B | 13.90 |
| Prestige Consumer Healthcare (PBH) | United States | $4.190B | 18.72 |
| Perrigo (PRGO) | Ireland | $3.610B | 9.15 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.346B | 15.24 |
| Envista Holdings (NVST) | United States | $3.178B | 26.41 |
| GN Store Nord (GNNDY) | Denmark | $2.155B | 17.85 |
| QuidelOrtho (QDEL) | United States | $2.102B | 14.46 |
| LeMaitre Vascular (LMAT) | United States | $1.865B | 41.69 |
| AtriCure (ATRC) | United States | $1.729B | 0.00 |
| Acuren (TIC) | United States | $1.228B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.196B | 12.14 |
| Green Thumb Industries (GTBIF) | United States | $1.101B | 24.76 |
| Neogen (NEOG) | United States | $1.077B | 13.78 |
| BioLife Solutions (BLFS) | United States | $1.046B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.016B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.972B | 12.42 |
| InMode (INMD) | Israel | $0.931B | 9.38 |
| Evolus (EOLS) | United States | $0.632B | 0.00 |
| CeriBell (CBLL) | United States | $0.619B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.571B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.564B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.563B | 0.00 |
| Valneva SE (VALN) | France | $0.523B | 0.00 |
| Owens & Minor (OMI) | United States | $0.515B | 4.27 |
| Surmodics (SRDX) | United States | $0.429B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.412B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.340B | 12.52 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.313B | 55.70 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.291B | 0.00 |
| Cerus (CERS) | United States | $0.275B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.272B | 22.90 |
| Sanara MedTech (SMTI) | United States | $0.260B | 0.00 |
| ZimVie (ZIMV) | United States | $0.255B | 11.61 |
| Cresco Labs (CRLBF) | United States | $0.250B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.239B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.231B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.217B | 0.00 |
| Quanterix (QTRX) | United States | $0.217B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.205B | 0.00 |
| Brainsway (BWAY) | Israel | $0.198B | 52.30 |
| Omeros (OMER) | United States | $0.196B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.195B | 0.00 |
| Biote (BTMD) | United States | $0.194B | 5.45 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.182B | 14.80 |
| Organigram Global (OGI) | Canada | $0.179B | 0.00 |
| Exagen (XGN) | United States | $0.157B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 16.72 |
| Vireo Growth (VREOF) | United States | $0.125B | 0.00 |
| Jin Medical (ZJYL) | China | $0.121B | 0.00 |
| Veru (VERU) | United States | $0.096B | 0.00 |
| MacroGenics (MGNX) | United States | $0.095B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.56 |
| TerrAscend (TSNDF) | Canada | $0.089B | 0.00 |
| Agape ATP (ATPC) | $0.077B | 0.00 | |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Zynex (ZYXI) | United States | $0.065B | 0.00 |
| Apyx Medical (APYX) | United States | $0.063B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.045B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.02 |
| Nephros (NEPH) | United States | $0.035B | 47.43 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.021B | 0.00 |
| Safety Shot (SHOT) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |